Botanix Pharmaceuticals Ltd
ASX:BOT

Watchlist Manager
Botanix Pharmaceuticals Ltd Logo
Botanix Pharmaceuticals Ltd
ASX:BOT
Watchlist
Price: 0.327 AUD -0.91% Market Closed
Market Cap: 641.2m AUD

Wall Street
Price Targets

BOT Price Targets Summary
Botanix Pharmaceuticals Ltd

Wall Street analysts forecast BOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOT is 0.51 AUD with a low forecast of 0.505 AUD and a high forecast of 0.525 AUD.

Lowest
Price Target
0.505 AUD
54% Upside
Average
Price Target
0.51 AUD
56% Upside
Highest
Price Target
0.525 AUD
61% Upside
Botanix Pharmaceuticals Ltd Competitors:
Price Targets
PFE
Pfizer Inc
25% Upside
AXSM
Axsome Therapeutics Inc
64% Upside
1666
Tong Ren Tang Technologies Co Ltd
26% Upside
1093
CSPC Pharmaceutical Group Ltd
5% Downside
214370
Caregen Co Ltd
20% Upside
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
6% Upside
326030
SK Biopharmaceuticals Co Ltd
54% Upside
MDWD
Mediwound Ltd
40% Upside

Revenue
Forecast

Revenue Estimate
Botanix Pharmaceuticals Ltd

The compound annual growth rate of Botanix Pharmaceuticals Ltd's revenue for the next 3 years is 675%.

N/A
Past Growth
675%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BOT's stock price target?
Price Target
0.51 AUD

According to Wall Street analysts, the average 1-year price target for BOT is 0.51 AUD with a low forecast of 0.505 AUD and a high forecast of 0.525 AUD.

What is Botanix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
675%

The compound annual growth rate of Botanix Pharmaceuticals Ltd's revenue for the next 3 years is 675%.

Back to Top